v3.26.1
Acquisitions (Additional Information) (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 05, 2025
Jun. 14, 2022
Apr. 30, 2026
Jan. 31, 2026
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
May 22, 2026
Apr. 16, 2026
Mar. 02, 2026
Jan. 20, 2026
Apr. 17, 2025
Jun. 11, 2024
Business Combination [Line Items]                              
Common stock, par value         $ 0.0001   $ 0.0001   $ 0.0001 $ 0.0001   $ 0.68      
Payment to acquire license             $ 100                
Common stock, shares issued         8,493,000   8,493,000   8,491,267           3,250,000
Preferred Stock, Redemption Amount                         $ 800    
Fair Value of Assets Acquired $ 45,100                            
Liabilities Assumed $ 47,100                            
Royalty expenses         $ 0 $ 100 $ 0 $ 100              
Accrued Royalty Payables               $ 200            
A-2 Preferred Stock | Business Combination [Member]                              
Business Combination [Line Items]                              
Cash consideration     $ 2,400                        
Series A Common Stock [Member]                              
Business Combination [Line Items]                              
Deemed Dividend         $ 1,200   $ 1,200                
Series A Common Stock [Member] | Business Combination [Member]                              
Business Combination [Line Items]                              
Common stock, shares issued                     1,000        
Vivasor Business Combination [Member] | Business Combination [Member]                              
Business Combination [Line Items]                              
Noncontrolling interest, Percentage 32.60%                            
Vivasor Business Combination [Member] | A-1 Preferred Stock | Business Combination [Member]                              
Business Combination [Line Items]                              
Business Combination, Price Per Share $ 0.00001                            
Agreed to purchase Stock 6,101,468                            
Aggregate purchase price of share $ 9,000                            
Vivasor Business Combination [Member] | A-2 Preferred Stock                              
Business Combination [Line Items]                              
Price Per Share         $ 1.97   $ 1.97                
Cash consideration       $ 1,100                      
Vivasor Business Combination [Member] | Series A Common Stock [Member] | Business Combination [Member]                              
Business Combination [Line Items]                              
Agreed to purchase Stock             203,382                
Cash consideration             $ 700                
Shah Agreement [Member] | A-2 Preferred Stock                              
Business Combination [Line Items]                              
Preferred Stock, Shares Issued                         254,228    
Preferred Stock, Redemption Amount                         $ 800    
Three I Fund Agreement [Member] | A-2 Preferred Stock                              
Business Combination [Line Items]                              
Preferred Stock, Shares Issued       101,691                      
Preferred Stock, Redemption Amount       $ 300                      
IPMC [Member] | Vivasor Business Combination [Member] | A-2 Preferred Stock | Business Combination [Member]                              
Business Combination [Line Items]                              
Agreed to purchase Stock     1,032,994 355,919                      
Patents [Member]                              
Business Combination [Line Items]                              
Amount due for New Drug Application             3,000                
Patents [Member] | Sorrento [Member]                              
Business Combination [Line Items]                              
Payment upon the achievement of net sales             20,000                
Scilex Bio JV [Member]                              
Business Combination [Line Items]                              
Common stock, shares issued                           5,000,000  
Scilex Bio JV [Member] | Semnur Merger Agreement And Sponsor Interest Purchase Agreement [Member]                              
Business Combination [Line Items]                              
Common stock, par value                           $ 0.00001  
License Agreement                              
Business Combination [Line Items]                              
Development milestones payment was recognized under other long-term liabilities         $ 200   200   $ 200            
License Agreement | Romeg License Agreement [Member]                              
Business Combination [Line Items]                              
Payment upon the achievement of net sales   $ 13,000                          
Royalty expenses         $ 200 $ 300 $ 300 $ 300